NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/04/2022
Back to search
Official data from USPTO
TRANSDERMAL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRANSDERMAL THERAPEUTICS
ST13
US500000085356818Class
44
Filing
85356818
Registration
4089271
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/04/2022
Trademark type
Word
Nice classes
44
Filing date
06/27/2011
Registration date
01/17/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2022
Last transaction
05/04/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
10/01/2010
First use in commerce
10/01/2010
Drawing code
4
Owner type
03
Owner location
Birmingham, AL
Examiner
BLOHM, LINDA
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Transdermal Therapeutics, Inc.
Representatives
Laura M. Jackman WALLACE, JORDAN, RATLIFF & BRANDT, L.L.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicespharmaceutical drug compounding for the purpose of pain management
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/04/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/04/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
01/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/17/2021
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/02/2017
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/02/2017
PLGL
ASSIGNED TO PARALEGAL
08/28/2017
ES8R
TEAS SECTION 8 RECEIVED
07/21/2017
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/17/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/12/2011
ALIE
ASSIGNED TO LIE
12/12/2011
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/21/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2011
CNRT
NON-FINAL ACTION MAILED
10/14/2011
CNRT
NON-FINAL ACTION WRITTEN
10/14/2011
DOCK
ASSIGNED TO EXAMINER
10/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2011
NWAP
NEW APPLICATION ENTERED
06/30/2011
Continuous trademark protection
Get notified about every new filing that threatens TRANSDERMAL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.